Comparison of the Effect of Minimal Invasive Lens Surgery and Traditional Cataract Surgery
Launched by SUN YAT-SEN UNIVERSITY · Apr 8, 2019
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
Patients with congenital cataract that requires surgical intervention are enrolled.
Then the participants are assigned to two groups: Group I: the participants receive a minimal invasive lens surgery, while in Group II, the participants receive a traditional cataract surgery. A secondary intraocular lens implantation is performed when the patient is two years old for both Group I and Group II. Investigators then compare the visual acuity, incidence of high intraocular pressure, incidence of visual axis opacification, uveitis and iris/pupil abnormality between two groups, to evaluate and co...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 1 month and 24 months
- • Uncomplicated congenital cataract (≥ 3 mm central dense opacity) in one or both eyes with an intact non-fibrotic capsular bag
- • Informed consent signed by a parent or legal guardian
- Exclusion Criteria:
- • confirmed or suspected hereditary cataract, including and not restricted to family history of congenital cataract
- • Intraocular pressure \>21 mmHg
- • Preterm birth (\<28 weeks)
- • Presence of other ocular diseases (keratitis, keratoleukoma, aniridia, glaucoma) or systemic disease (congenital heart disease, ischemic encephalopathy)
- • History of ocular diseases (any congenital eye diseases, such as, congenital cataract, congenital glaucoma, congenital aniridia) in the family
- • History of ocular trauma
- • Microcornea
- • Persistent hyperplastic primary vitreous
- • Rubella
- • Lowe syndrome
About Sun Yat Sen University
Sun Yat-sen University, a prestigious institution located in Guangzhou, China, is dedicated to advancing medical research and healthcare innovations. As a leading clinical trial sponsor, the university leverages its extensive academic resources and collaboration with top-tier medical professionals to conduct rigorous clinical studies. Committed to improving patient outcomes and contributing to global health knowledge, Sun Yat-sen University focuses on a wide range of therapeutic areas, employing cutting-edge methodologies to ensure the integrity and efficacy of its research initiatives. Through its clinical trials, the university aims to foster scientific advancements and enhance the quality of care provided to patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Yizhi Liu, M.D,Ph.D
Principal Investigator
Zhongshan Ophthalmic Center, Sun Yat-sen University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials